Nienke Losekoot

487 total citations
14 papers, 400 citations indexed

About

Nienke Losekoot is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Nienke Losekoot has authored 14 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Infectious Diseases. Recurrent topics in Nienke Losekoot's work include Biochemical and Molecular Research (6 papers), HIV/AIDS drug development and treatment (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Nienke Losekoot is often cited by papers focused on Biochemical and Molecular Research (6 papers), HIV/AIDS drug development and treatment (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Nienke Losekoot collaborates with scholars based in Netherlands, Japan and Switzerland. Nienke Losekoot's co-authors include Godefridus J. Peters, Richard J. Honeywell, Kees Smid, Henk M.W. Verheul, Ietje Kathmann, Irene V. Bijnsdorp, Elisa Giovannetti, Masakazu Fukushima, Joline S.W. Lind and Arjan W. Griffioen and has published in prestigious journals such as Cancer Research, British Journal of Cancer and Biochemical Pharmacology.

In The Last Decade

Nienke Losekoot

13 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nienke Losekoot Netherlands 11 217 160 66 54 45 14 400
Angela Hu United States 11 258 1.2× 139 0.9× 44 0.7× 44 0.8× 39 0.9× 23 470
N. R. Attard United Kingdom 6 185 0.9× 137 0.9× 57 0.9× 32 0.6× 35 0.8× 11 572
G. A. Taylor United Kingdom 13 211 1.0× 157 1.0× 79 1.2× 36 0.7× 31 0.7× 20 422
Steven M. Schmid United States 11 194 0.9× 132 0.8× 39 0.6× 35 0.6× 27 0.6× 14 389
Masanori Umeda Japan 15 275 1.3× 145 0.9× 41 0.6× 30 0.6× 113 2.5× 59 533
H Fridborg Sweden 12 239 1.1× 225 1.4× 30 0.5× 46 0.9× 47 1.0× 20 480
Lisa A. Raedler 14 185 0.9× 307 1.9× 57 0.9× 25 0.5× 79 1.8× 53 649
A L Jackman United Kingdom 9 302 1.4× 230 1.4× 78 1.2× 28 0.5× 43 1.0× 12 515
EJ Estlin United Kingdom 12 137 0.6× 82 0.5× 77 1.2× 37 0.7× 40 0.9× 25 454
G Pizzorno United States 13 301 1.4× 199 1.2× 27 0.4× 55 1.0× 45 1.0× 19 558

Countries citing papers authored by Nienke Losekoot

Since Specialization
Citations

This map shows the geographic impact of Nienke Losekoot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nienke Losekoot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nienke Losekoot more than expected).

Fields of papers citing papers by Nienke Losekoot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nienke Losekoot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nienke Losekoot. The network helps show where Nienke Losekoot may publish in the future.

Co-authorship network of co-authors of Nienke Losekoot

This figure shows the co-authorship network connecting the top 25 collaborators of Nienke Losekoot. A scholar is included among the top collaborators of Nienke Losekoot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nienke Losekoot. Nienke Losekoot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Peters, Godefridus J., Richard J. Honeywell, Elisa Giovannetti, et al.. (2014). Selection of the Best Blood Compartment to Measure Cytidine Deaminase Activity to Stratify for Optimal Gemcitabine or Cytarabine Treatment. Nucleosides Nucleotides & Nucleic Acids. 33(4-6). 403–412. 20 indexed citations
2.
Peters, Godefridus J., Ietje Kathmann, Clara Lemos, et al.. (2013). Folate homeostasis of cancer cells affects sensitivity to not only antifolates but also other non-folate drugs: effect of MRP expression. Pteridines. 24(1). 81–86. 3 indexed citations
3.
Peters, Godefridus J., Kees Smid, Ietje Kathmann, et al.. (2013). Metabolism, mechanism of action and sensitivity profile of fluorocyclopentenylcytosine (RX-3117; TV-1360). Investigational New Drugs. 31(6). 1444–1457. 32 indexed citations
4.
Seinen, Margien L., Dirk P. van Asseldonk, Nanne K.H. de Boer, et al.. (2013). The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: Results from a prospective pharmacological study. Journal of Crohn s and Colitis. 7(10). 812–819. 41 indexed citations
5.
Hovingh, Suzanne, Hans M. Rodermond, Nienke Losekoot, et al.. (2013). Decay of γ-H2AX foci correlates with potentially lethal damage repair in prostate cancer cells. Oncology Reports. 29(6). 2175–2180. 20 indexed citations
6.
7.
Smid, Kees, Nienke Losekoot, Richard J. Honeywell, et al.. (2011). Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126. Investigational New Drugs. 30(5). 1908–1916. 42 indexed citations
8.
Bijnsdorp, Irene V., Frank A.E. Kruyt, Nienke Losekoot, et al.. (2011). Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors. British Journal of Cancer. 104(7). 1185–1192. 62 indexed citations
9.
Temmink, Olaf H., Irene V. Bijnsdorp, Henk‐Jan Prins, et al.. (2010). Trifluorothymidine Resistance Is Associated with Decreased Thymidine Kinase and Equilibrative Nucleoside Transporter Expression or Increased Secretory Phospholipase A2. Molecular Cancer Therapeutics. 9(4). 1047–1057. 25 indexed citations
10.
Honeywell, Richard J., Elisa Giovannetti, Nienke Losekoot, et al.. (2010). Simple and selective method for the determination of various tyrosine kinase inhibitors used in the clinical setting by liquid chromatography tandem mass spectrometry. Journal of Chromatography B. 878(15-16). 1059–1068. 83 indexed citations
11.
Losekoot, Nienke, Kees Smid, Ietje Kathmann, et al.. (2010). Induction of Resistance to the Lipophilic Cytarabine Prodrug Elacytarabine (CP-4055) in CEM Leukemic Cells. Nucleosides Nucleotides & Nucleic Acids. 29(4-6). 394–399. 15 indexed citations
12.
Bijnsdorp, Irene V., Reto A. Schwendener, Herbert Schott, et al.. (2009). Cellular pharmacology of multi- and duplex drugsconsisting of ethynylcytidine and 5-fluoro-2′-deoxyuridine. Investigational New Drugs. 29(2). 248–257. 12 indexed citations
13.
Noordhuis, Paul, et al.. (2008). Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell lines. Biochemical Pharmacology. 76(1). 53–61. 42 indexed citations
14.
Bijnsdorp, Irene V., Reto A. Schwendener, Herbert Schott, et al.. (2008). In vitro activity and mechanism of action of a duplex and multidrug of ethynylcytidine and 5-fluorodeoxyuridine. Nucleic Acids Symposium Series. 52(1). 651–651. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angela Hu Breakdown of academic impact, for papers by N. R. Attard Breakdown of academic impact, for papers by G. A. Taylor Breakdown of academic impact, for papers by Steven M. Schmid Breakdown of academic impact, for papers by Masanori Umeda Breakdown of academic impact, for papers by H Fridborg Breakdown of academic impact, for papers by Lisa A. Raedler Breakdown of academic impact, for papers by A L Jackman Breakdown of academic impact, for papers by EJ Estlin Breakdown of academic impact, for papers by G Pizzorno
Rankless by CCL
2026